In the public interest?

Science Translational Medicine

Volumn 4, Issue 144, 2012, Pages

  Sayres, Lauren C ^a   Allyse, Megan ^a   Goodspeed, Taylor A ^a   Cho, Mildred K ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CLINICAL PRACTICE; CLINICAL RESEARCH; COST BENEFIT ANALYSIS; DNA DETERMINATION; GENE TECHNOLOGY; GENETIC SCREENING; HEALTH CARE COST; HEALTH CARE INDUSTRY; HEALTH CARE POLICY; LICENSING; MARKETING; PATENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PUBLIC HEALTH; SHORT SURVEY; STRATEGIC PLANNING; TRISOMY 21;

DNA; FEMALE; FETUS; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84864524706     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003612     Document Type: Short Survey

References (12)

1. H. T. Greely, Get ready for the fl ood of fetal gene screening. Nature 469, 289-291 (2011).
2. Y. M. Lo, K. C. Chan, H. Sun, E. Z. Chen, P. Jiang, F. M. Lun, Y. W. Zheng, T. Y. Leung, T. K. Lau, C. R. Cantor, R. W. Chiu, Maternal plasma DNA sequencing reveals the genomewide genetic and mutational profi le of the fetus. Sci. Transl. Med. 2, 61ra91 (2010).
3. L. C. Sayres, M. K. Cho, Cell-free fetal nucleic acid testing: A review of the technology and its applications. Obstet. Gynecol. Surv. 66, 431-442 (2011).
4. E. Waltz, Industry waits for fallout from Cabilly. Nat. Biotechnol. 25, 699-700 (2007).
5. L. B. Andrews, Genes and patent policy: Rethinking intellectual property rights. Nat. Rev. Genet. 3, 803-808 (2002).
6. M. K. Cho, S. Illangasekare, M. A. Weaver, D. G. Leonard, J. F. Merz, Eff ects of patents and licenses on the provision of clinical genetic testing services. J. Mol. Diagn. 5, 3-8 (2003).
7. J. F. Merz, Disease gene patents: Overcoming unethical constraints on clinical laboratory medicine. Clin. Chem. 45, 324-330 (1999).
8. J. F. Merz, A. G. Kriss, D. G. Leonard, M. K. Cho, Diagnostic testing fails the test. Nature 415, 577-579 (2002).
9. A. J. Sehnert, B. Rhees, D. Comstock, E. de Feo, G. Heilek, J. Burke, R. P. Rava, Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin. Chem. 57, 1042-1049 (2011).
10. National Science Foundation mission: http://www.nsf. gov/nsf/nsfpubs/ straplan/mission.htm;
11. Wellcome Trust policies: http://www.wellcome.ac.uk/About-us/Policy/ Policy-and-position-statements/WTD002762.htm;
12. H. Wallace, Coulter Foundation: http://www.whcf.org/ about/the-coulter- foundation.